“My research interest includes studying preclinical models of melanoma to identify drug combinations that can be rapidly translated to patients. Following graduation from the MD-PhD program, I plan to pursue training in a dermatology residency and post-doctoral research program. My long-term goal is to become a principal investigator of a translational and reverse translational research lab that focuses on therapeutics in cutaneous malignancies.”
Poster# 1890: Chloroquine synergizes with MEK1/2 targeted therapy through dual YAP and lysosomal inhibition in GNAQ/11 mutant uveal melanoma